Sponsor: TriLink BioTechnologiesDuring this presentation, which is part of TriLink BioTechnologies gene editing and cell therapy webinar series, Dr. Gaudelli will discuss how her group has transformed off-the-shelf base editors from a technology developed in academia to a promising therapeutic tool through engineering, screening, and directed evolution.
Sponsor: IsoPlexisIn this GEN webinar, learn how Lonza’s Cocoon™ cell therapy manufacturing platform and IsoPlexis’ IsoLight™ single-cell proteomics system can be used together to advance the future of cancer immunotherapy.
Sponsor: SynthegoIn this GEN webinar, sponsored by Synthego, we will discuss the development of a fully automated genome engineering platform that empowers large scale functional investigation of disease-associated variants to identify the causal variants and causal genes, in a cost- and time-effective manner.
Sponsor: Horizon DiscoveryIn this GEN webinar, sponsored by Horizon Discovery, we will provide a field overview of how iPSCs, coupled with genome editing, hold the potential to expand our understanding of human diseases further, and facilitate the development of new therapies.
Sponsor: Terumo BCTIn this GEN webinar, sponsored by Terumo BCT, we hear from a team of scientists who will discuss the parameters for the fill/finish and cryopreservation steps of a cell therapy manufacturing process. We will also looked at data from a typical manual fill and finish process compared to data from an automated process using the Finia® Fill and Finish System.